Skip to main content
. 2020 Sep 28;11:4878. doi: 10.1038/s41467-020-18702-3

Fig. 1. Genomic alterations in pulmonary sarcomatoid carcinoma (PSC).

Fig. 1

a Spectrum of the key molecular alterations in PSC. The genomic alterations of smokers and nonsmokers are demonstrated in the left and right side, respectively. The overall number of somatic mutations and clinicopathological data are shown at the top. The type of base-pair substitutions of each sample are displayed in the bottom panel. b Mutational signatures in our cohort (n = 56). Samples, annotated for the histological subtype, smoking status and tumor mutation burden, are ordered by the contribution of signature 4. Source data are provided as a Source data file.